Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease.

Arastoo, Mohammad; Lofthouse, Richard; Penny, Lewis K; Harrington, Charles R; Porter, Andy; Wischik, Claude M; Palliyil, Soumya

Arastoo, Mohammad; Lofthouse, Richard; Penny, Lewis K; Harrington, Charles R; Porter, Andy; Wischik, Claude M; Palliyil, Soumya.

Afiliação

Arastoo M; Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZP, UK.
Lofthouse R; Scottish Biologics Facility, University of Aberdeen, Aberdeen AB25 2ZP, UK.
Penny LK; Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZP, UK.
Harrington CR; Scottish Biologics Facility, University of Aberdeen, Aberdeen AB25 2ZP, UK.
Porter A; Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZP, UK.
Wischik CM; Scottish Biologics Facility, University of Aberdeen, Aberdeen AB25 2ZP, UK.
Palliyil S; Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZP, UK.

Int J Mol Sci ; 21(22)2020 Nov 17.

Article em En | MEDLINE | ID: mdl-33212983

Assuntos

Doença de Alzheimer/diagnóstico; Doença de Alzheimer/metabolismo; Proteínas tau/metabolismo; Biomarcadores/metabolismo; Humanos

Palavras-chave

Alzheimer's disease; Tau; biomarkers; blood; cerebrospinal fluid; diagnostics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas tau / Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google